HomeDNLI • NASDAQ
add
Denali Therapeutics Inc
Previous close
$21.25
Day range
$18.67 - $20.80
Year range
$14.58 - $33.32
Market cap
2.75B USD
Avg Volume
937.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.95M | -1.48% |
Net income | -107.19M | -7.89% |
Net profit margin | — | — |
Earnings per share | -0.63 | 12.50% |
EBITDA | -120.92M | -8.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 836.56M | -24.58% |
Total assets | 1.45B | 17.56% |
Total liabilities | 135.52M | 14.41% |
Total equity | 1.32B | — |
Shares outstanding | 143.92M | — |
Price to book | 2.32 | — |
Return on assets | -20.83% | — |
Return on capital | -21.94% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -107.19M | -7.89% |
Cash from operations | -59.14M | 32.31% |
Cash from investing | 93.66M | -7.19% |
Cash from financing | -18.56M | -844.74% |
Net change in cash | 15.96M | -0.51% |
Free cash flow | -41.51M | 2.30% |
About
Founded
2013
Headquarters
Website
Employees
390
